Genetic Diagnoses and Postnatal Outcomes in a Prenatal Cohort of Arthrogryposis Multiplex Congenita
In brief
Sequencing found a genetic diagnosis in half of tested prenatal arthrogryposis cases
In this 94-pregnancy referral cohort, next-generation sequencing identified a molecular diagnosis in 24 of 48 cases with no diagnosis from initial chromosome testing. Outcomes varied sharply: 6 of 7 newborns with fetal akinesia deformation sequence died, while 10 of 13 with isolated arthrogryposis survived, often with significant care needs. The small, specialized-center cohort limits how broadly these figures apply.
- Journal
- Prenatal diagnosis (Q1)
- Published
- 15 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Lylach Haizler-Cohen, Devon O'Brien, Elizabeth Field, Isabelle Thiffault, Laura K Vricella, Teresa N Sparks
- PMID
- 43035101
- DOI
- 10.1002/pd.70310
Why clinicians should know about it
- Picked for Genetics (clinical) (paper of the day, 20 November 2026): Prenatal genomic diagnoses and outcomes in a genetically heterogeneous condition
Abstract
OBJECTIVE: Describe genetic diagnoses and characterize postnatal outcomes in a prenatal cohort of arthrogryposis multiplex congenita (AMC) evaluated at a quaternary fetal center. METHODS: Retrospective cohort study of pregnancies referred between 2014 and 2026 for contractures involving ≥ 2 body areas. We categorized cases into three groups using the Hall classification. Demographics, prenatal imaging, genetic results, autopsy findings, and postnatal outcomes were collected. RESULTS: Ninety-four pregnancies were included: 15 with isolated arthrogryposis, 32 with arthrogryposis and systemic anomalies excluding the central nervous system (CNS), and 47 with arthrogryposis and CNS involvement or fetal akinesia deformation sequence (FADS). Genetic findings in our cohort included 18 aneuploidies, 3 copy number variants and 25 single gene disorders. Of pregnancies with non-diagnostic cytogenetic findings that underwent next-generation sequencing (NGS), 50% (24/48) had a molecular diagnosis. Neonates with FADS had notably poor outcomes, including high mortality (86%, 6/7) and failed intubation (50%, 3/6) rates. Of neonates with isolated arthrogryposis, 77% (10/13) survived but frequently required respiratory or feeding support, orthopedic surgery, ambulation assistance and had neurodevelopmental delays. CONCLUSIONS: AMC is genetically heterogeneous with frequent underlying single gene disorders, supporting the use of NGS in prenatal diagnosis. Neonatal morbidity and mortality remain high, particularly with FADS.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.